alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
ex_10-6.htm






FIRST AMENDMENT TO THE RUBY TUESDAY, INC.


EXECUTIVE LIFE INSURANCE PREMIUM PLAN







THIS FIRST AMENDMENT is made as of this 30th day of November, 2012, by RUBY TUESDAY, INC. (the “Primary Sponsor”), a corporation organized and existing under the laws of the State of Georgia.







W I T N E S S E T H:







WHEREAS, the Primary Sponsor maintains the Ruby Tuesday, Inc. Executive Life Insurance Premium Plan (the “Plan”), which was established by indenture effective as of January 1, 2004; and







WHEREAS, the Primary Sponsor desires to amend the Plan to permit the plan administrator to designate members from among a select group of management and highly compensated employees as eligible for participation in the Plan, even if they are then ineligible for participation in the Ruby Tuesday, Inc. Executive Supplemental Pension Plan.







NOW, THEREFORE, the Plan is hereby amended, effective as of December 1, 2012, by deleting the existing Section 2.6 and substituting therefor the following:







“2.6           ‘Eligible Employee’ shall mean an employee of the Plan Sponsor who is among a select group of management or highly compensated employees within the meaning of Section 201(2) of ERISA and who is either (a) a participant in the Ruby Tuesday, Inc. Executive Supplemental Pension Plan (or any successor plan), or (b) otherwise designated in writing as eligible for participation in the Plan by the Plan Administrator pursuant to Section 3.1.”







Except as specifically amended hereby, the Plan shall remain in full force and effect as prior to this First Amendment.







IN WITNESS WHEREOF, the Primary Sponsor has caused this First Amendment to be executed as of the day and year first above written.







RUBY TUESDAY, INC.







By:  /s/ Samuel E. Beall, III                                                              


Samuel E. Beall, III


Chief Executive Officer and President







ATTEST:







By:  Scarlett May                                                    


Scarlett May


Secretary







[CORPORATE SEAL]
exhibit105.htm


 


 


KODAK







March 14, 2016







Re:  Amendment to Employment Agreement







Dear Jeff:







With Kodak’s implementation of the Exempt Employee Flexible Time-Off Plan, a copy of which is attached hereto (the “Plan”), an amendment to your employment agreement dated March 10, 2014 (your “Agreement”) is necessary.  Pursuant to this letter agreement, Section 5(b) of your Agreement is hereby amended, effective February 1, 2016, to provide that you are eligible for vacation benefits in accordance with the terms of the Plan.  The treatment of your accrued vacation as of March 31, 2016, is addressed by the terms of the Plan.  All other terms of your Agreement remain in full force and effect.







Please indicate your acceptance of the amendment to your Agreement by signing the acknowledgement below and returning this letter to me.







Thank you.


 


EASTMAN KODAK COMPANY


 


By:  /s/Karen M Kelly


Name  Karen M Kelly


Title  Director, Total Rewards and Operational Excellence and VP, Human Resources


 


EXECUTIVE


 


/s/ Jeffrey J. Clarke


Jeffrey J. Clarke







Attachment:  Exempt Employee Flexible Time-Off Plan






  





1











  








Benefit Plan 1A.03b


Exempt Employee Flexible Time-Off Plan


Effective Date:  February 1, 2016


As Amended:  XXXXX XX, 2016


No. of Pages: 1







Exempt Employee Flexible Time-Off Plan












Effective on February 1, 2016, Exempt and Executive Employees do not accrue or track vacation time.  Exempt and Executive Employees will not receive a payment for unused vacation time upon termination from the Company.







Exempt and Executive Employees will be expected to take vacation at their discretion.  Scheduling of vacation by Exempt and Executive Employees is subject to departmental operating requirements and advance supervisory approval, unless it is substituted for unpaid leave protected under the Family and Medical Leave Act of 1993 (see the Kodak Family and Medical Leave Plan for more information regarding this option).







For Exempt and Executive Employees in California, Colorado or Illinois, with remaining accrued vacation on March 31, 2016, such vacation will be retained.  Vacation usage for such employees will continue to be tracked, and upon exhaustion of the remaining accrued vacation, such employees will become subject to the terms of this policy.







For employees who are reclassified as exempt or non-exempt during the middle of a calendar year, the provisions of section 4.05 of the Non-Exempt Employee Vacation Plan will apply.  At the beginning of the next calendar year, newly-classified Exempt and Executive Employees will start with a clean slate and there will no longer be carryover or accrued vacation.
















  





2
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the annual report on Form 10-K of Torchlight Energy Resources, Inc. (the "Company") for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the Covered Report"), I, Thomas Lapinski, Chief Executive Officer of the Company, pursuant to 18 U.S.C. Sec.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that:  The Covered Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and  The information contained in the Covered Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  IN WITNESS WHEREOF, I have executed this certificate as of this 14th day of April, 2011.   /s/ Thomas Lapinski By: Thomas Lapinski, Chief Executive Officer  Date: April 14, 2011
| 1.   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| Signatures                   |   | Title                           |   | Date              |
|------------------------------|--------|---------------------------------|--------|-------------------|
|                         |   |                            |   |              |
| /s/ James WinsorJames Winsor |   | Chief Executive OfficerDirector |   | November 30, 2010 |

----
P. 1



# OAR Box 1812 Prepped by Ollie Stewart



### Document

Number: 

# 289 ) IV-C-

2 Docket Number: 

# 4-fc*-* 3

Printed 11/3/2008 10:13:06

AM Sheet 289 of 307P. 2 

# C CJJ ZQ.y Mr . Frank S . Swai n Chie f Counse l for Advocac y U.S . Smal l Busines s Administratio n Washington , D C 2041 6 Dea r Mr . Swain : Thank yo u fo r your lette r o f Septembe r 29 , 198 9 conveying you r concern s ove r potentia l smal l busines s impact s o f our propose d control s fo r on-highwaydiese l fue l quality . A s yo u hav e expresse d it , smal l marketer s fac e a serie s o f potentia l advers e impact s associate d wit h the need t o handl e a newgrad e o f diese l fue l beginnin g i n lat e 1993 . Th e concern s yo u raise d hav e als o bee n expresse d directl y t o u s b yvariou s petroleu

mmarketers . I n respons e t o bot h you r an d thei r concerns , w e ar e nowundertaking additional.-stud yt o furthe r defin e an d quantif ysmal l markete r impacts . Ou r genera l approac h t o thi s stud yha s alread

ybee n describe d t o yo u i n meeting s wit h m yAn n Arbo r staff . Yo u have als o requeste d a n extensio n o f th e publi c commen t perio d t o allo

wfo r reviewo f the result s o f ou r study . A t thi s tim

e I believe i t i s prematur e t o respon d t o you r request . The need fo r additiona l publi c commen t can bes t b e determine d whe n w e hav e the result s o f our ne wwor k i n han d an d ca n mor e full yunderstan d th e gravit yo f whateve r impact s may occur . Onc e again , than

k yo u fo r you r comments , whic h ar e bein g place d i n the publi c docke t fo r the rulemaking . W e look forward t o workin

g wit h yo u t o reduc e smal l markete r impact s o f ou r ne wrule s a s muc h a s w e possibl ycan . Sincerely , ORIGINAL SIGNED S V E.CHAR C D . IVJD. / Willia mG . Rosenber g Assistan t Administrato r fo r Ai r an

d Radiatio n cc : Docke t A-86-0 3
From: haglercarla@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:27:51 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

CARLA Hagler

Lacombe, LA 70445
No. 62178.

#### Judson Sheldon Division National Carloading Corporation *v.*United States,

protest 309592-K (A) (New York).

Opinion by

Wilson, J.

In accordance with stipulation of counsel that the merchandise consists of flavoring extract the same in all material respects as that the subject of *R. U. Delapenha & Co.*v. *United States*(39 Cust. Ct. 136, C. D. 1918), the claim of the plaintiffs was sustained.
No. 67047.

protests 58/2917, etc. (New York).

#### G. Hirsch Sons, Inc., et al. *v.*United States,

Opinion by

Ford, J.

In accordance with stipulation of counsel that the merchandise consists of insignia similar in all material respects to those involved in Abstract 66583, the claim of the plaintiffs was sustained.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1490 Engrossed in House (EH)]

                In the House of Representatives, U. S.,

                                                    September 25, 2008.
    Resolved, That the requirement of clause 6(a) of rule XIII for a two-thirds 
vote to consider a report from the Committee on Rules on the same day it is 
presented to the House is waived with respect to any resolution reported on any 
legislative day through September 27, 2008, providing for consideration or 
disposition of a measure to provide incentives for energy production and 
conservation, to extend certain expiring provisions, to provide individual 
income tax relief, and for other purposes.
            Attest:

                                                                          Clerk.
```
**EXHIBIT 31.1**

**CHIEF EXECUTIVE OFFICER CERTIFICATION**

**REQUIRED BY RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE**

**ACT OF 1934, AS AMENDED**

I, J. Michael French, certify that: 

1. I have reviewed this annual report on Form 10-K/A of MDRNA, Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have: 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is beingprepared; 

b) designed such internal control over financial reporting, or caused such internal controlover financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally acceptedaccounting principles; 

c) evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; 

d) disclosed in this report any change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to theregistrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

a) all significant deficiencies in the design or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in theregistrant’s internal control over financial reporting. 

 

Date:April 30, 2010
No. 59695.

#### Earbrooke Novelty Co. *v.*United States,

protest 271712-K (A) (New York).

Opinion by

Ford, J.

In accordance with stipulation of counsel that the merchandise consists of silk scarves or squares similar in all material respects to those the subject of *United States*v. *The Specialty House, Inc., Bryant & Heffernan, Inc., et al.*(42 C. C. P. A. 136, C. A. D. 585), the claim of the plaintiff was sustained.
No. 67070.

protest 61/2746 (New York).

#### Gimbel Bros., Inc. *v.*United States,

Opinion by

Johnson, J.

In accordance with stipulation of counsel that the merchandise consists of figures similar in all material respects to those passed upon in *Wm. S. Pitcairn Corp.*v. *United States*(39 C.C.P.A. 15, C.A.D. 458), the claim of the plaintiff was sustained.
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsStatistical Emulator for Expensive Classification SimulatorsExpensive simulators prevent any kind of meaningful analysis to be performed on the phenomena they model. To get around this problem the concept of using a statistical emulator as a surrogate representation of the simulator was introduced in the 1980's. Presently, simulators have become more and more complex and as a result running a single example on these simulators is very expensive and can take days to weeks or even months. Many new techniques have been introduced, termed criteria, which sequentially select the next best (most informative to the emulator) point that should be run on the simulator. These criteria methods allow for the creation of an emulator with only a small number of simulator runs. We follow and extend this framework to expensive classification simulators.Document ID20160006302Acquisition SourceLangley Research CenterDocument TypeTechnical Memorandum (TM)AuthorsRoss, Jerret*(Wichita State Univ. Wichita, KS, United States)*Samareh, Jamshid A.*(NASA Langley Research Center Hampton, VA, United States)*Date AcquiredMay 17, 2016Publication DateApril 1, 2016Subject CategoryComputer Programming And SoftwareReport/Patent NumberL-20675NF1676L-23725NASA/TM-2016-219174Funding Number(s)WBS: WBS 388496.04.01.02Distribution LimitsPublicCopyrightPublic Use Permitted.Available DownloadsNameType20160006302.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
From: bslminorg@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:46:43 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

All of OBAMACARE should be abolished. I have lived in a country that practices social health care. It

doesn't work and never will!

Sincerely,

Joe Daigle

Prairieville, LA 70769
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-K
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                      15,620,000
<SECURITIES>                                         0
<RECEIVABLES>                               29,418,000
<ALLOWANCES>                                 1,066,000
<INVENTORY>                                  5,180,000
<CURRENT-ASSETS>                            50,340,000
<PP&E>                                       9,448,000
<DEPRECIATION>                               6,816,000
<TOTAL-ASSETS>                              83,518,000
<CURRENT-LIABILITIES>                       16,155,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                   123,695,000
<OTHER-SE>                                 (56,422,000)
<TOTAL-LIABILITY-AND-EQUITY>                83,518,000
<SALES>                                     30,925,000
<TOTAL-REVENUES>                            72,695,000
<CGS>                                       18,261,000
<TOTAL-COSTS>                               54,895,000
<OTHER-EXPENSES>                                     0<F1>
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                             141,000
<INCOME-PRETAX>                            (13,331,000)<F2>
<INCOME-TAX>                                    55,000
<INCOME-CONTINUING>                        (13,386,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (13,386,000)
<EPS-BASIC>                                       0.43
<EPS-DILUTED>                                     0.43
<FN>
<F1>NOT SHOWN SEPARATELY WHEN REPORTING FORM 10-K.
<F2>INCLUDES EQUITY INTEREST IN JOINT VENTURE, NET OF TAX.
</FN>


</TABLE>